Stock Analiz

ArriVent BioPharma, Inc. (AVBP) stock forecast and price target

Price $13.01 · data as of November 13, 2026

12-month price target

Average target$26.40
Upside / downside+102.9%
Analysts10
ConsensusStrong buy
Low $22.00Average $26.40High $30.00

Gold marker: average target · white marker: today’s price ($13.01)

Analyst ratings

Strong buy 0Buy 11Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-3.94+8.7%$5M
Next fiscal year
ends December 31, 2027
$-3.62+8.1%$7M
Next quarter
ends December 31, 2026
$-1.01−29.0%$0
Quarter after
ends December 31, 2026
$-0.95−21.8%$3M

Consensus of the analysts covering ArriVent BioPharma, updated daily. In the last 30 days 5 estimates were raised and 0 lowered.

Frequently asked questions

What is the ArriVent BioPharma stock price target?

The average 12-month target from 10 analysts is $26.40, 102.9% above the current price of $13.01 Targets range from $22.00 to $30.00.

Is ArriVent BioPharma a buy according to analysts?

The consensus rating is “Strong buy” (11 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is ArriVent BioPharma expected to earn?

Analysts expect EPS of $-3.94 for the fiscal year ending December 31, 2026 and $-3.62 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.